Why Not Cap Medicines' MRPs At 16% Above Retailer Prices? Supreme Court Asks
Why Not Cap Medicines' MRPs At 16% Above Retailer Prices? Supreme Court Asks Live Law Supreme Court questions steep mark-ups on cancer drugs, calls pricing disparity ‘carnage’ The Hindu 'This is carnage': SC questions huge gap in medicine prices, seeks 16% margin cap Deccan Herald ‘Corporate hospitals don’t spare anyone,’ SC observes on exorbitant prices of...
Key Takeaways
- Why Not Cap Medicines' MRPs At 16% Above Retailer Prices?
- Supreme Court Asks Live Law Supreme Court questions steep mark-ups on cancer drugs, calls pricing disparity ‘carnage’ The Hindu 'This is carnage': SC questions huge gap in medicine prices, seeks 16% margin cap Deccan Herald ‘Corporate hospitals don’t spare anyone,’ SC observes on exorbitant prices of cancer drugs Telegraph India Private hospitals functioning like industries, not service providers: Supreme Court Bar and Bench
- Full details and original dispatch available below.
Why Not Cap Medicines' MRPs At 16% Above Retailer Prices? Supreme Court Asks Live Law Supreme Court questions steep mark-ups on cancer drugs, calls pricing disparity ‘carnage’ The Hindu 'This is carnage': SC questions huge gap in medicine prices, seeks 16% margin cap Deccan Herald ‘Corporate hospitals don’t spare anyone,’ SC observes on exorbitant prices of cancer drugs Telegraph India Private hospitals functioning like industries, not service providers: Supreme Court Bar and Bench
Original Publisher Attribution
This summary was curated from Live Law.